8-K: Progyny Stockholders Reject Executive Compensation Plan at Annual Meeting

Progyny, Inc. announced the results of its 2025 Annual Meeting of Stockholders, where shareholders elected directors and ratified auditors, but notably did not approve the compensation of named executive officers on an advisory basis.

Summary

• Progyny, Inc. held its 2025 Annual Meeting of Stockholders on May 22, 2025, with 88.39% of eligible shares represented.
• Stockholders elected all three Class III director nominees—Norman Payson, M.D., Debra Morris, and Elizabeth Bierbower—to serve until the 2028 Annual Meeting.
• The selection of Ernst & Young LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2025, was ratified by stockholders with 75,154,219 votes for.
• Stockholders did not approve, on an advisory (non-binding) basis, the compensation of the company's named executive officers, with 43,948,036 votes against compared to 24,399,909 votes for.

Sentiment

Score: 4

Explanation: The sentiment is moderately negative due to the significant shareholder rejection of the executive compensation plan, which, while non-binding, signals a notable governance concern. The successful election of directors and ratification of auditors are routine and do not offset this negative sentiment entirely.

Positives

• All three Class III director nominees (Norman Payson, M.D., Debra Morris, and Elizabeth Bierbower) were successfully elected to the Board of Directors.
• The selection of Ernst & Young LLP as the independent registered public accounting firm for fiscal year 2025 was ratified by a significant majority of votes (75,154,219 votes for).

Negatives

• Stockholders did not approve, on an advisory (non-binding) basis, the compensation of the company's named executive officers, with 43,948,036 votes against versus 24,399,909 votes for, indicating significant shareholder dissent on executive pay.

Management Comments

• Peter Anevski, Chief Executive Officer, signed the report on behalf of Progyny, Inc.

Industry Context

The advisory vote on executive compensation is a common practice in corporate governance, reflecting shareholder sentiment on management pay. A 'no' vote, while non-binding, often signals shareholder dissatisfaction and can prompt boards to review their compensation practices to align with investor expectations.

Comparison to Industry Standards

• While specific comparable companies are not mentioned, a 'no' vote on executive compensation, even if advisory, is generally considered a significant expression of shareholder discontent. In the broader market, companies often aim for strong shareholder support on executive compensation to demonstrate good governance and alignment with shareholder interests.
• The election of all director nominees and ratification of the auditor are standard outcomes for most public companies, indicating routine operational governance.

Corporate Governance

Stakeholder Impact

• Shareholders: Expressed significant dissent regarding executive compensation, which could influence future compensation decisions and potentially impact investor confidence.
• Management: The 'no' vote on executive compensation puts pressure on the Board and management to re-evaluate and potentially revise their compensation strategies to better align with shareholder expectations.

Next Steps

• The elected Class III directors will serve until the company's 2028 Annual Meeting of Stockholders.
• Ernst & Young LLP will serve as the independent registered public accounting firm for the fiscal year ending December 31, 2025.

Key Dates

Recommendation

Keywords

Progyny, PGNY, Annual Meeting, Stockholder Vote, Executive Compensation, Director Election, Auditor Ratification, Corporate Governance, SEC Filing, 8-K